1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Dynatronics Corporation

Dynatronics Corporation

DYNT
Dynatronics CorporationUS flagOther OTC
0.04
USD
- -
- -
403,612.00Market Cap
Dynatronics Corporation
DYNT
(Other OTC)

Recent

price

0.04

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
59.29
60.44
61.3
61.79
58.46
54.46
57.76
56.18
56.72
48.63
37.94
26.02
15.46
12.42
10.49
9.51
4.17
Revenue per Share
0.19
0.78
0.51
-0.05
-0.09
-0.54
-8.65
-4.2
-6.81
-2.64
-1.04
-2.1
0.39
-1.32
-1.46
-1
-0.52
Basic EPS, GAAP
2.7
5.29
3.02
-0.57
1.07
0.65
-2.25
-1.35
-2.61
0.39
0.06
1.36
0.08
-1.46
0.05
-0.54
0.06
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
0.03
0.08
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-2.74
-1.97
12.4
-1.61
-1.72
-2.26
-6.73
3.47
6.06
7.35
5.53
5.42
5.67
3.84
2.29
1.81
0.59
Book Value per Share
10.75
11.64
11.71
11.59
11.73
11.46
7.99
3.18
-5.13
-3.41
-2.67
-0.82
1.77
0.66
-0.48
-1.15
-0.82
Tangible Book Value per Share
1
1
1
1
1
1
1
1
1
1
2
2
3
4
4
3
7
Basic Weighted Avg Shares
32
33
33
32
30
27
29
30
36
64
63
53
48
44
41
33
28
Sales/Revenue/Turnover
2.04
3.3
2.05
0.08
0.35
-0.68
-3.73
-5.57
-4.68
-1.94
-1.27
-5.6
-7.87
-10.73
-11.95
-6.99
-8.52
Operating Margin (%)
- -
- -
- -
- -
1
1
- -
1
1
1
2
2
2
1
1
1
1
Depreciation Expense
- -
- -
- -
- -
- -
- -
-2
-2
-2
-2
-1
-3
2
-4
-5
-3
-3
Net Income, GAAP
25.8
39.44
35.33
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
0.32
1.29
0.83
-0.07
-0.15
-0.99
-7.73
-6.26
-5.22
-2.49
-1.47
-6.41
4.19
-9.01
-12.25
-8.29
-9.95
Profit Margin (%)
4
5
5
4
4
3
8
6
6
7
6
8
12
9
4
3
1
Working Capital
3
3
2
2
2
1
4
4
4
3
3
9
4
3
4
3
3
LT Debt
6
7
7
6
6
6
7
6
12
21
21
20
26
22
17
14
12
Total Equity
3.31
4.96
3.63
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
7.41
12.49
5.6
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-150.56
-51.62
-18.21
-42.66
8.44
-30.25
-50.14
-45.55
-64.71
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'25
ST Debt
3
4
3
LT Borrowings
- -
- -
- -
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
8
8
8
Shares Outstanding
6
7
9
Market Capitalization
1
1
1

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'25
Total Current Assets
10
11
9
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
3
3
3
Inventories
5
7
5
Total Current Liabilities
7
9
8
Payables & Accruals
4
5
5
ST Debt
3
4
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16%
-5.83%
-15.99%
Free Cash Flow
-151.59%
-190.07%
-1,106.02%
Net Income, GAAP
44.85%
-41.5%
-45.76%
Sales/Revenue/Turnover
4.47%
-12.13%
-19.89%
Total Cash Common Dividend
- -
-1.27%
5.77%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
12
11
9
8
41
2024
9
8
8
7
33
2025
8
7
6
7
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.18
-0.27
-0.36
-0.63
-1.46
2024
-0.12
-0.27
-0.17
-0.16
-1
2025
-0.09
-0.13
-0.13
-0.03
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Nureca Limited (NURECA.BO)
Cochlear Limited (COH.AX)
Novocure Ltd (NVCR)
Allurion Technologies Inc. (ALUR)
Medica Group Plc (MGP.L)
Nova Eye Medical Limited (ELXMF)
Business
Dynatronics Corporation Dynatronics Corporation (DYNT), a medical device company founded in 1979 and headquartered in Eagan, Minnesota, designs, manufactures, markets, and sells restorative products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and distributors in the United States, Asia, Latin America, the Middle East, and internationally. Core products and services include orthopedic soft bracing such as cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products; therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy including TriWave light therapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes under brands including Dynatron, Dynatron Solaris, Solaris Plus, and Thermostim; power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and treadmills; and clinical supplies such as exercise bands and tubing, lotions and gels, paper products, and athletic tape, marketed under brands including Bird & Cronin, Hausmann, PROTEAM, and Mammoth. In recent developments, the company transitioned its common stock listing from Nasdaq to the OTCQB Venture Market in July 2024 following noncompliance with Nasdaq's minimum bid price requirement; divested its Bird & Cronin and Hausmann divisions in 2021 to refocus on core therapeutic modalities and reduce debt; shifted production of most therapeutic modalities to in-house operations in fiscal 2026 to cut costs, enhance quality control, and improve supply chain reliability; and pursues an acquisition strategy to consolidate manufacturers in physical therapy, rehabilitation, orthopedics, pain management, and athletic training amid ongoing cost reduction initiatives and inventory optimization to address operating losses and liquidity challenges.

Company News

APIChatGPT

  • defenseworld.net

    Head to Head Analysis: Dynatronics (NASDAQ:DYNT) versus Interpace Biosciences (OTCMKTS:IDXG)

  • defenseworld.net

    Dynatronics (NASDAQ:DYNT) Stock Crosses Below 200-Day Moving Average – Here’s Why

  • defenseworld.net

    Dynatronics (NASDAQ:DYNT) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

  • defenseworld.net

    Dynatronics (NASDAQ:DYNT) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

  • defenseworld.net

    Dynatronics (NASDAQ:DYNT) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

  • newsfilecorp.com

    Dynatronics Corporation Provides Update Regarding Transition to OTC Markets Group

  • newsfilecorp.com

    Dynatronics Corporation Reports Third Quarter Fiscal Year 2024 Financial Results

  • newsfilecorp.com

    Dynatronics Corporation Schedules Conference Call to Report Results for Third Quarter Fiscal Year 2024

  • investorplace.com

    Why Is Dynatronics (DYNT) Stock Up 93% Today?

  • newsfilecorp.com

    Dynatronics Corporation Reports Second Quarter Fiscal Year 2024 Financial Results

  • newsfilecorp.com

    Dynatronics Corporation Schedules Conference Call to Report Results for Second Quarter Fiscal Year 2024

  • newsfilecorp.com

    Dynatronics Corporation Announces Andrew Hulett as New Board Member

  • newsfilecorp.com

    Dynatronics Corporation Reports First Quarter Fiscal Year 2024 Financial Results

  • zacks.com

    Dynatronics Corporation (DYNT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

  • newsfilecorp.com

    Dynatronics Appoints Gabe Ellwein as Chief Financial Officer

  • newsfilecorp.com

    Dynatronics Corporation Schedules Conference Call to Report Results for First Quarter Fiscal Year 2024

  • newsfilecorp.com

    Dynatronics Corporation Announces Brian Baker as New Chief Executive Officer and Director

  • zacks.com

    Dynatronics Corporation (DYNT) Reports Q4 Loss, Tops Revenue Estimates

  • newsfilecorp.com

    Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Update on CEO Succession Plan

  • newsfilecorp.com

    Dynatronics Corporation Schedules Conference Call to Report Results for Fourth Quarter and Fiscal Year 2023